Expression of interferon-β and tumour necrosis factor-α messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route

Immunology

Volumn 128, Issue 1 PART 2, 2009, Pages

  Jeevan, Amminikutty ^a   Bonilla, Diana Lucia ^a   McMurray, David Neil ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Bacillus Calmette Gu rin; Cytokine mRNA; Guinea pig; Lung digest cells; Mycobacterium tuberculosis; T cell proliferation

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA; CONCANAVALIN A; MITOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RESPONSIVE ELEMENT; GUINEA PIG; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYSTEM; SPLEEN CELL; TUBERCULOSIS; VACCINATION; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; LUNG; LUNG TUBERCULOSIS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; SPLEEN; STEM CELL; T LYMPHOCYTE;

ANIMALS; BCG VACCINE; CELL PROLIFERATION; CONCANAVALIN A; DISEASE MODELS, ANIMAL; GUINEA PIGS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; LUNG; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MITOGENS; MYCOBACTERIUM TUBERCULOSIS; RNA, MESSENGER; SPLEEN; STEM CELLS; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUBERCULIN; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 68249141399     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02962.x     Document Type: Article

References (43)

1. Kaufmann S. Towards new leprosy and tuberculosis vaccines. Microbiol Sci 1987 4 : 324 8.
2. Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis 1982 125 : 8 15.
3. Young LS, Inderlied CB, Berlin OG, Gottlieb MS. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis 1986 8 : 1024 33.
4. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006 368 : 1575 80.
5. Smith D, Harding G, Chan J, Edwards M, Hank J, Muller D, Sobhi F. Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea pigs. J Biol Stand 1979 7 : 179 97.
6. Udani PM. BCG vaccination in India and tuberculosis in children: newer facets. Indian J Pediatr 1994 61 : 451 62.
7. Roche PW, Triccas JA, Winter N. BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol 1995 3 : 397 401.
8. Canetti G. The Tubercle Bacillus in the Pulmonary Lesion in Man. New York : Springer Publishing Co., 1955.
9. Stewart GR, Robertson BD, Young DB. Tuberculosis: a problem with persistence. Nat Rev Microbiol 2003 1 : 97 105.
10. Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 1990 145 : 149 54.
11. Bhatt K, Salgame P. Host immune response to Mycobacterium tuberculosis. J Clin Immunol 2007 27 : 347 62.
12. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993 178 : 2249 54.
13. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989 56 : 731 40.
14. Cooper AM, D'Souza C, Frank AA, Orme IM. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect Immun 1997 65 : 1317 20.
15. Holscher C, Atkinson RA, Arendse B, Brown N, Myburgh E, Alber G, Brombacher F. A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol 2001 167 : 6957 66.
16. Verreck FA, de Boer T, Langenberg DM et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004 101 : 4560 5.
17. Majlessi L, Simsova M, Jarvis Z et al. An increase in antimycobacterial Th1 cell response in prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect Immun 2006 74 : 2128 37.
18. Mittrucker H-W, Steinhoff U, Kohler A, Krause M, Lazar D, Mex P, Miekley D. Poor correlation between BCG vaccine-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci USA 2007 104 : 12434 9.
19. Soares A, Scriba TJ, Joseph S et al. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 2008 180 : 3569 77.
20. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998 101 : 2364 9.
21. Kemijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, Bosland M, Vilcek J. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med 1993 178 : 1435 40.
22. Keane J, Gershon S, Wise RP, Levens EM, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 2001 345 : 1098 104.
23. Holt PG. Regulation of antigen presenting cell(s) in lung and airway tissues. Eur Respir J 1993 6 : 120 9.
24. McCombs CC, Michalski JP, Westerfield BT, Light RW. Human alveolar macrophages suppress the proliferative response of peripheral blood lymphocytes. Chest 1982 82 : 266 71.
25. Apt AS, Kramnik IB, Moroz AM. Regulation of T-cell proliferative responses by cells from solid lung tissue of M. tuberculosis-infected mice. Immunology 1991 73 : 173 9.
26. Jeevan A, Sawant K, Cho H, McMurray DN. Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-β activation. Clin Exp Immunol 2007 149 : 387 98.
27. Grover AA, Kim HK, Wiegeshaus EH, Smith DW. Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70°C. J Bacteriol 1967 94 : 832 40.
28. McMurray DN. Disease model: pulmonary tuberculosis. Trends Mol Med 2001 7 : 135 7.
29. Lyadova IV, Eruslanov EB, Khaidukov SV et al. Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease. J Immunol 2000 165 : 5921 31.
30. Jeevan A, Yoshimura T, Lee KE, McMurray DN. Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination. Infect Immun 2003 71 : 354 64.
31. Allen SS, McMurray DN. Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs. Infect Immun 2003 71 : 4271 7.
32. Jeevan A, McFarland CT, Yoshimura T, Skwor T, Cho H, Lasco T, McMurray DN. Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation. Infect Immun 2006 74 : 213 24.
33. Ly LH, Russell MI, McMurray DN. Microdissection of the cytokine milieu of pulmonary granulomas from tuberculous guinea pigs. Cell Microbiol 2007 9 : 1127 36.
34. Yamamoto T, Lasco TL, Uchida K et al. Mycobacterium bovis BCG vaccination modulates TNF-α production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs. Tuberculosis 2007 87 : 155 65.
35. + transforming growth factor-β-producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response. Clin Exp Immunol 2007 148 : 537 45.
36. Ly LH, Russell MI, McMurray DN. Cytokine profiles in primary and secondary pulmonary granulomas of guinea pigs with tuberculosis. Am J Respir Cell Mol Biol 2008 38 : 455 62.
37. Fenton MJ, Vermeulen MW, Kim S, Burdick M, Strieter RM, Kornfeld H. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun 1997 65 : 5149 56.
38. Wang J, Wakeham J, Harkness R, Xing Z. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 1999 103 : 1023 9.
39. Appleberg R, Silva MT. T-cell dependent chronic neutrophilia during mycobacterial infections. Clin Exp Immunol 1989 78 : 478 48.
40. Lasco TM, Turner OC, Cassone L, Sugawara I, Yamada H, McMurray DN, Orme IM. Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect Immun 2004 72 : 1147 9.
41. Flynn JL, Goldstein MM, Triebold KJ, Dalton DK, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992 89 : 12013 7.
42. + T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J Exp Med 2004 200 : 1479 89.
43. Upham JW, Strickland DH, Bilyk N, Robinson BW, Holt PG. Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion. Immunology 1995 84 : 142 7.